Polyglycolic Acid Suture Material: Comprehensive Analysis Of Synthesis, Properties, And Clinical Applications

Molecular Structure And Polymer Chemistry Of Polyglycolic Acid Suture Material

Polyglycolic acid suture material is derived from glycolic acid (hydroxyacetic acid), the smallest α-hydroxy acid, through two principal synthetic routes. The first method involves direct polycondensation of glycolic acid or its methyl ester, though this approach typically yields only low molecular weight oligomers (Mw ≤20,000) with insufficient mechanical properties for surgical applications18. The second and industrially preferred route employs ring-opening polymerization of glycolide, the cyclic dimer of glycolic acid, which readily produces high molecular weight PGA (Mw >100,000) suitable for suture fabrication51318.

The chemical structure of polyglycolic acid consists of repeating ester linkages (-CO-O-) connecting methylene units, represented as [-O-CH₂-CO-]ₙ. This simple aliphatic polyester structure confers several critical properties:

• High crystallinity (45-55%) due to regular chain packing, contributing to initial tensile strength of 60-70 kg/cm² for multifilament sutures24
• Melting point ranging from 215-225°C for homopolymer, enabling melt extrusion processing1114
• Glass transition temperature (Tg) approximately 35-40°C, affecting handling characteristics at body temperature
• Hydrolytic susceptibility through ester bond cleavage, initiating biodegradation in physiological environments13

The molecular weight distribution significantly influences suture performance. Patent US3698853A demonstrates that PGA fibers with intrinsic viscosity of 1.2-1.8 dL/g (corresponding to Mw 80,000-150,000) provide optimal balance between processability and mechanical strength2. Lower molecular weights result in premature degradation, while excessively high molecular weights increase melt viscosity beyond practical extrusion limits1114.

Copolymerization with lactide (LA) produces poly(glycolide-co-lactide) (PGLA) sutures with modulated properties. A 90:10 glycolide:lactide ratio (VICRYL®) reduces crystallinity to 30-40%, improving flexibility while maintaining adequate strength retention1610. The comonomer incorporation lowers melting point to 195-205°C and accelerates hydrolytic degradation by disrupting crystalline domains112.

Synthesis Routes And Industrial Production Of Polyglycolic Acid Suture Material

Ring-Opening Polymerization Process

The industrial synthesis of polyglycolic acid suture material predominantly utilizes ring-opening polymerization (ROP) of glycolide under controlled conditions51318. The process involves:

1. Glycolide monomer preparation: Glycolic acid undergoes dehydration polycondensation to form low molecular weight prepolymer, followed by thermal depolymerization at 220-260°C under reduced pressure (0.1-10 mmHg) to yield crude glycolide18. Recrystallization from ethyl acetate or acetic anhydride produces high-purity glycolide (>99.5%) essential for high molecular weight polymer synthesis1318.

2. Polymerization reaction: Purified glycolide is polymerized at 180-220°C in the presence of tin-based catalysts (typically stannous octoate at 0.01-0.1 wt%) for 2-6 hours under inert atmosphere513. The reaction proceeds via coordination-insertion mechanism, achieving molecular weights of 100,000-200,000 with polydispersity index (PDI) of 1.8-2.514.

3. Catalyst deactivation and stabilization: Residual catalyst is neutralized using phosphorous acid or triphenyl phosphite (0.05-0.2 wt%) to prevent post-polymerization degradation during storage and processing1114. Heat stabilizers such as hindered phenolic antioxidants are incorporated at 0.1-0.5 wt% to maintain polymer integrity during melt extrusion14.

4. Continuous production integration: Patent WO2020091254A describes an integrated twin-screw extrusion system that combines polymerization, devolatilization, and direct fiber spinning in a continuous process, reducing thermal history effects and improving product consistency14. This approach eliminates intermediate pelletization steps, preserving molecular weight and minimizing hydrolytic degradation during processing.

Fiber Formation And Suture Manufacturing

Polyglycolic acid suture material is produced through melt spinning followed by drawing and heat-setting operations24:

• Melt extrusion: PGA polymer is extruded through spinnerets at 230-250°C with nozzle draft ratios of 4.0-10.0, producing as-spun filaments with diameter of 50-200 μm416
• Drawing process: Filaments are drawn at 80-120°C to draw ratios of 4-8×, inducing molecular orientation and increasing crystallinity to 50-60%4. This step enhances tensile strength from 2-3 g/denier (as-spun) to 6-8 g/denier (drawn)4
• Heat setting: Drawn fibers are annealed at 160-200°C under tension for 10-60 seconds to stabilize crystalline structure and reduce shrinkage48
• Braiding or twisting: Multifilament sutures are produced by braiding 8-16 individual filaments, while monofilament sutures are formed from single extruded and drawn fibers810

Patent KR20080060851A reports that PGA multifilament sutures with tenacity of 6.5-7.5 g/denier and in vivo strength retention of 60-95% after 2 weeks can be consistently manufactured using optimized spinning and drawing parameters4.

Mechanical Properties And Performance Characteristics Of Polyglycolic Acid Suture Material

Tensile Strength And Knot Security

Polyglycolic acid suture material exhibits superior initial mechanical properties compared to traditional absorbable sutures:

• Straight tensile strength: 60-70 kg/cm² for USP size 2-0 braided sutures, approximately 30% higher than chromic catgut of equivalent diameter24
• Knot-pull strength: 40-45% of straight tensile strength, requiring 4-5 throws for secure knot formation28
• Elongation at break: 15-30% for multifilament constructions, providing moderate flexibility during surgical manipulation24
• Elastic modulus: 6-8 GPa for oriented PGA fibers, contributing to dimensional stability under physiological loads10

The knot security of polyglycolic acid suture material is influenced by surface friction characteristics. Uncoated PGA multifilaments exhibit relatively high coefficient of friction (μ = 0.25-0.35), which enhances knot holding but may cause tissue drag during passage817. Surface coating with calcium stearate (0.5-2.0 wt%) or caprolactone-based polymers reduces friction coefficient to 0.15-0.20, improving handling while maintaining adequate knot security with 3-4 throws6817.

Biodegradation Kinetics And Strength Retention

The in vivo degradation of polyglycolic acid suture material proceeds through bulk hydrolysis of ester linkages, catalyzed by water and enzymatic activity1310:

1. Initial phase (0-14 days): Minimal strength loss (<10%) as water penetrates the polymer matrix without significant chain scission110
2. Rapid degradation phase (14-28 days): Accelerated hydrolysis reduces molecular weight below critical entanglement threshold, causing 50% strength loss at 21-25 days for PGA homopolymer sutures110
3. Fragmentation phase (28-90 days): Continued hydrolysis produces water-soluble oligomers (Mw <5,000) that are metabolized via citric acid cycle310
4. Complete absorption (90-120 days): Residual polymer fragments are phagocytosed and enzymatically degraded to glycolic acid, which is converted to carbon dioxide and water13

Patent US20100028395A1 describes thermal steam treatment of PGA sutures to accelerate degradation rate while maintaining initial strength, achieving 50% strength loss at 14-18 days versus 21-25 days for untreated controls1. This modification is beneficial for rapidly healing tissues such as oral mucosa or pediatric applications.

The degradation rate is influenced by several factors:

• Crystallinity: Higher crystalline content (>55%) slows hydrolytic penetration, extending strength retention to 28-35 days10
• Fiber diameter: Monofilament sutures (200-400 μm) degrade more slowly than multifilaments (50-100 μm per filament) due to reduced surface area-to-volume ratio810
• Coating composition: Hydrophobic coatings (calcium stearate, polycaprolactone) delay initial water uptake by 3-7 days, slightly prolonging strength retention6817
• Tissue environment: Acidic or enzymatically active tissues (infected wounds, gastrointestinal tract) accelerate degradation by 20-40% compared to neutral pH environments13

Surface Modification And Coating Technologies For Polyglycolic Acid Suture Material

Lubricity Enhancement Coatings

Uncoated polyglycolic acid suture material exhibits relatively high surface friction, causing tissue drag and potential trauma during passage through dense tissues817. Several coating strategies have been developed to improve handling characteristics:

Calcium stearate coating: The most widely used coating system, applied at 0.5-2.0 wt% via solvent dip-coating or melt-coating processes68. Patent EP2161041A1 demonstrates that calcium stearate reduces coefficient of friction from 0.30 to 0.18 while maintaining knot security, with coating durability exceeding 6 months under ambient storage8. The coating mechanism involves formation of oriented stearate monolayers on fiber surfaces through ionic interaction between carboxylate groups and surface hydroxyl end-groups.

Polycaprolactone-based coatings: Copolymers of ε-caprolactone with glycolide or lactide (5-15 mol% caprolactone) provide absorbable lubricious coatings with glass transition temperatures below 0°C, ensuring flexibility at body temperature817. Patent WO1991011163A1 reports that 1-3 wt% coating of poly(glycolide-co-caprolactone) (85:15 molar ratio) reduces tissue drag by 40-50% compared to uncoated PGA sutures while maintaining complete absorbability within 90-120 days17.

Polyhydric alcohol-glycolic acid copolymers: Patent WO1991011163A1 describes coatings synthesized from glycolic acid and polyhydric alcohols (glycerol, sorbitol) at 2-10 wt%, providing thermoplastic character suitable for conventional coating methods17. These coatings exhibit excellent lubricity (friction coefficient 0.12-0.16) and complete metabolic compatibility, being hydrolyzed to naturally occurring metabolites.

Antimicrobial Functionalization

Secondary infection remains a significant complication in surgical wound healing, with suture-associated infections occurring in 2-5% of clean surgical procedures6. Antimicrobial functionalization of polyglycolic acid suture material addresses this challenge through several approaches:

Grapefruit extract (naringin) incorporation: Patent US20110137310A1 describes incorporation of naringin (a flavonoid glycoside with broad-spectrum antimicrobial activity) into PGLA suture coatings at 0.5-5.0 wt%6. In vitro testing demonstrates >99.9% reduction in Staphylococcus aureus and Escherichia coli colonization after 24-hour exposure, with sustained antimicrobial activity for 14-21 days6. The naringin is released through coating erosion and polymer hydrolysis, providing temporal antimicrobial protection during the critical wound healing phase without systemic accumulation concerns associated with nano-silver particles6.

Triclosan coating: Commercial antimicrobial PGA sutures (VICRYL® Plus) incorporate triclosan at 0.3-0.5 wt% within the coating layer, providing zone of inhibition of 1-2 mm against common surgical pathogens for 7-14 days. The coating technology balances antimicrobial efficacy with minimal tissue irritation and complete absorption.

Chlorhexidine incorporation: Chlorhexidine diacetate (0.5-2.0 wt%) can be incorporated into absorbable coatings, providing sustained antimicrobial activity through controlled release as the coating degrades. This approach is particularly effective for high-risk surgical sites (contaminated wounds, immunocompromised patients).

Clinical Applications And Surgical Specialties Utilizing Polyglycolic Acid Suture Material

General Surgery And Wound Closure

Polyglycolic acid suture material is extensively used for fascial closure, subcutaneous tissue approximation, and gastrointestinal anastomoses in general surgery123. The material's high initial strength (60-70 kg/cm²) and predictable degradation profile (50% strength loss at 21-25 days) align well with typical wound healing timelines for most soft tissues110.

Abdominal wall closure: Braided PGA sutures (USP size 0 or 1) provide secure fascial approximation with tensile strength exceeding physiological loads (20-30 kg/cm²) for 3-4 weeks, sufficient for collagen deposition and wound maturation12. Clinical studies report dehiscence rates of 0.5-1.2% for PGA fascial closure, comparable to permanent sutures but eliminating long-term foreign body reactions2.

Gastrointestinal anastomoses: The rapid strength loss of PGA sutures (50% at 21 days) matches the accelerated healing kinetics of intestinal mucosa, which achieves 70-80% of normal tensile strength within 14-21 days13. Multifilament PGA sutures are preferred over monofilaments for bowel anastomoses due to superior knot security and reduced risk of anastomotic leak (1-3% vs. 3-5% for monofilaments)810.

Subcutaneous closure: Fine PGA sutures (USP size 3-0 or 4-0) provide excellent subcutaneous tissue approximation with minimal inflammatory response and complete absorption within 90-120 days, eliminating suture sinus formation associated with permanent materials13.

Obstetrics And Gynecology Applications

Polyglycolic acid suture material is the preferred choice for episiotomy repair, cesarean section uterine closure, and vaginal surgery due to its biocompatibility and predictable absorption123:

Episiotomy repair: Rapidly absorbing PGA sutures (modified through steam treatment to achieve 50% strength loss at 14-18 days) reduce postpartum perineal pain and dyspareunia compared to conventional PGA or chromic catgut1. Patent US20080161776A1 demonstrates that steam-treated PGA sutures maintain adequate strength for 10-14 days (sufficient for perineal healing) while degrading more rapidly than standard PGA, reducing long-term foreign body sensation1.

Cesarean section: Braided PGA sutures (USP size 0 or 1) provide secure uterine closure with tensile strength retention exceeding 60% at 14 days, adequate for myometrial healing110.